Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CDMO
CRO
WuXi sharpens focus by selling off clinical research units
By separating itself from its China-based CRO and site management businesses, the company hopes to prioritize growth of its CRDMO platform.
Darren Incorvaia
Oct 28, 2025 12:27pm
Lonza to buy rapid microbial testing firm Redberry SAS
Oct 28, 2025 5:15am
Almac sets aside $48M to launch new trial coordinator platform
Oct 14, 2025 9:00am
CDMO Catalent strengthens ADC pipeline with $10M Lisata pact
Oct 9, 2025 7:45am
Chinese CRO ChemPartner gets ready to debut US research facility
Aug 26, 2025 2:57pm
WuXi AppTec posts sales decline but picks up new business in Q3
Oct 29, 2024 8:25am